The global burden of overweight-obesity and its association with economic status, benefiting from STEPs survey of WHO member states: A meta-analysis
[We need to] recognise the societal influences, with food production, pollution, community access to green space, exercise, working practices The issue we have extends beyond you eating food
Proc Natl Acad Sci USA 81:50075011 Migoya E, Miller J, Luo W-L et al (2010) Sitagliptin and metformin increase active GLP-1 by complementary mechanisms in treatment-nave patients with type 2 diabetes
Leigh Baxt, who has followed all of this closely, points out that most of the injectable substances already on that compounding list have considerably more safety data behind them than these peptides do
First of all, Ozempic is still under patent protection
Rotating injection sites prevents tissue damage and scarring